Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-037724

Chief Medical Officer sold 2,000 shares at an average $92.89 ($185,786)

  • Chief Medical Officer acquired 2,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bowden Christopher · Chief Medical Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2018-06-12 Exercise or conversion : show line 1 in the form +2,000 $35.16 $70,320 2,881 D
2018-06-12 Sale : show line 2 in the form −1,800 $92.84 $167,112 1,081 D
2018-06-12 Sale : show line 3 in the form −200 $93.37 $18,674 881 D
Open-market sales · 2,000 sh · avg $92.89 · $185,786

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-06-12 Exercise or conversion : show line 4 in the form Stock option (right to buy) −2,000 95,000 D
Loading xslF345X03/doc4.xml…